Neuralink Raises Additional Capital

Neuralink, a Prime Unicorn Index component, has raised an additional $43 million in capital, as a recent Form D filing indicates. Form D filings are a type of filing with the Securities and Exchange Commission (SEC) that allows companies to offer securities under a Regulation D exemption or Section 4(6) exemption, providing essential information about the company for investors, including the size and date of the offering, and the names and addresses of the company’s executive officers. Neuralink filed a Form D in relation to its Series D round on August 8, 2023, which disclosed a total investment amount of $280 million. This was amended on November 22, 2023, to show an additional $43 million raised, bringing the total investment amount to over $323 million. 

Neuralink is an American neurotechnology company at the forefront of developing implantable brain-computer interfaces (BCIs). Headquartered in Fremont, California, the company was founded to merge the human brain with artificial intelligence to unlock human potential and address unmet medical needs. Neuralink’s mission is to create a generalized brain interface that not only restores autonomy to those with medical conditions but also paves the way for enhancing human capabilities in the future. The company has built a brain-computer interface (BCI) experience that enables fast and reliable computer control, prioritizing ease of use and aiming to improve lives by restoring independence. 

Neuralink has raised a total of $595.45 million over four rounds, with its most recent round being the $323.24 million Series D. This values the company at $3.45 billion at $19.03 per preferred share. Investors include The Founders Fund, Vy Capital, Google Ventures, DFJ Growth, Gigafund, Valor Equity Partners, and Craft Ventures.

See how Neuralink has performed against the Prime Unicorn Index below.